A Clinical Study to Explore the Safety and Efficacy of CD33 CAR-T Cell in Relapsed/Refractory Acute Myeloid Leukemia
Clinical trial NCT06762132 · RECRUITING
Trial details
- NCT number
- NCT06762132
- Sponsor
- Zhejiang University
- Status
- RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-10
- Primary completion
- 2027-10-30
- Enrollment
- 27
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.